Cipla Limited
CIPLA
Xếp hạng trong cổ phiếu
#1821
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Giá cổ phiếu
$14.47
Đồng bộ lần cuối: 2026-10-21
Vốn hóa thị trường
$11.69B
Thay đổi (1 ngày)
-0.94%
Thay đổi (1 năm)
-23.41%
Quốc gia
IN
Giao dịch Cipla Limited (CIPLA)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Cipla Limited (CIPLA)
Giá đóng cửa cao nhất: $14.60 vào 2026-10-01
Giá đóng cửa thấp nhất: $0.61 vào 1999-01-01
Giá đóng cửa thấp nhất: $0.61 vào 1999-01-01
Lịch sử giá cổ phiếu của Cipla Limited từ 1999 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | -7.62% |
| 2025 | -3.98% |
| 2024 | 18.60% |
| 2023 | 9.73% |
| 2022 | 11.40% |
| 2021 | 12.45% |
| 2020 | 63.56% |
| 2019 | -11.32% |
| 2018 | -20.85% |
| 2017 | 10.86% |
| 2016 | -13.38% |
| 2015 | -3.99% |
| 2014 | 59.08% |
| 2013 | -16.32% |
| 2012 | 21.62% |
| 2011 | -22.64% |
| 2010 | 8.98% |
| 2009 | 94.47% |
| 2008 | -26.68% |
| 2007 | -6.96% |
| 2006 | 48.26% |
| 2005 | 38.40% |
| 2004 | 24.79% |
| 2003 | 48.49% |
| 2002 | -23.94% |
| 2001 | 11.29% |
| 2000 | -35.33% |
| 1999 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
